$10,000 invested in these ASX healthcare shares 5 years ago is now worth…

These healthcare stocks have brought big returns for investors 

| More on:
Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare shares are often regarded as less represented in the Australian economy. 

While this is true compared to financials (big banks) and resources (mining giants), there are healthcare shares have brought big returns for investors in recent times. 

Projecting which ones will produce these big returns is another challenge. 

In the last 5 years, the S&P/ASX 200 Health Care (ASX:XHJ) index has grown just 2%. 

Here are two of the outliers.

Pro Medicus Ltd (ASX: PME)

Pro Medicus Ltd (ASX: PME) is a provider of medical imaging technology globally. 

The company is recognised as a leading supplier of radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualisation solutions for medical practices and hospitals.

Its share price lay dormant for many years, before gaining some momentum in the late 2010s. 

Five years ago its share price sat at roughly $25.

Since then, it has seen rapid growth to become one of the largest healthcare stocks by market capitalisation in Australia. 

For holders of this stock, it's been the gift that keeps on giving. 

Pro Medicus was the second best performing ASX 200 healthcare shares last financial year, with 99% share price growth.

At the time of writing, its share price sits at $314.20. 

A $10,000 investment in Pro Medicus five years ago would be worth approximately $124,290 today – a 1,143% return.

This is before taking into consideration any dividends or reinvented earnings. 

Can the bull run continue?

Its success has come on the back of high margins, zero debt, a sticky client base, and strong earnings growth.

However, based on reporting from The Motley Fool's Brownwyn Allen, experts believe its share price could be overvalued right now. 

Sigma Healthcare Ltd (ASX: SIG)

Sigma Healthcare engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label.

The share price for this ASX healthcare stock remained flat for much of the last five years, before taking off in 2024. 

In total, it is up 367.19% over the past 5 years. 

This included 130% in FY25 alone, making it the best performing healthcare stock. 

A $10,000 investment in Sigma Healthcare five years ago would be worth approximately $46,718.75 today – a 367% return.

Is it still a buy?

Yesterday my colleague Bernd Struben reported that one broker in particular doesn't recommend adding more shares to your portfolio today.

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Polynovo shares fall despite yesterday's upbeat update. Here's what investors are watching

Polynovo shares slide after a solid update as investors wait for clearer growth signals.

Read more »